Targeted Therapy Group
Professor Harrington’s Targeted Therapy Group aims to develop new cancer therapies that selectively target cancer cells. This is accomplished by assessing combinations of viral, drug and immune therapies with radiation as a means of boosting both direct cytotoxic and indirect immune-related effects against cancers.